Mutations in ompK36 differentially impact in vitro synergy of meropenem/vaborbactam and ceftazidime/avibactam in combination with other antibiotics against KPC-producing Klebsiella pneumoniae

OBJECTIVES: Ceftazidime/avibactam and meropenem/vaborbactam are preferred agents for Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae (KPC-Kp) infections and are often used in combination with other agents. We aimed to characterize the synergy of combinations against KPC-Kp with var...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogers, Tara M, Kline, Ellen G, Griffith, Marissa P, Jones, Chelsea E, Rubio, Abigail M, Squires, Kevin M, Shields, Ryan K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600568/
https://www.ncbi.nlm.nih.gov/pubmed/37901589
http://dx.doi.org/10.1093/jacamr/dlad113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600568/
https://www.ncbi.nlm.nih.gov/pubmed/37901589
http://dx.doi.org/10.1093/jacamr/dlad113

Ejemplares similares